Free Trial

Curaleaf Q4 2023 Earnings Report

Curaleaf logo
$1.49 +0.02 (+1.36%)
(As of 12/20/2024 05:55 PM ET)

Curaleaf EPS Results

Actual EPS
-$0.01
Consensus EPS
-$0.05
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

Curaleaf Revenue Results

Actual Revenue
$345.27 million
Expected Revenue
$336.64 million
Beat/Miss
Beat by +$8.63 million
YoY Revenue Growth
N/A

Curaleaf Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

Curaleaf Earnings Headlines

Cannabis commission OKs first research facility license
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Curaleaf: Start Of A New Era
Curaleaf price target lowered to $5 from $7 at Roth MKM
Curaleaf Holdings (CURLF) Receives a Buy from Roth MKM
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

View Curaleaf Profile

More Earnings Resources from MarketBeat

Upcoming Earnings